Expert Radar
Dr. Vandana Abramson, MD, MSTR
Leader, Vanderbilt Health (Nashville, TN)
Master of Science in Translational Research, University of Pennsylvania
Dr. Vandana G. Abramson has specialized experience in the field of Medical Oncology. They earned their BA in English and Molecular and Cellular Biology from the University of California, Berkeley, their MD from the University of Chicago Pritzker School of Medicine, and their MSTR from the University of Pennsylvania. After completing their residency in Medicine at Brigham and Women's Hospital, they went on to complete a fellowship in Hematology & Oncology at the Perelman School of Medicine at the University of Pennsylvania. Previously, they held roles as an Associate Professor at Vanderbilt University School of Medicine and Leader and Interim Co-Leader at Vanderbilt-Ingram Cancer Center. Currently, they work as a Physician at Vanderbilt Health, Co-Leader at Vanderbilt-Ingram Cancer Center, and Professor at the Vanderbilt University School of Medicine.
v*********@v****.org
(917) ***-****
Nashville, Tennessee
Get a FREE Demo of Dr. Vandana Abramson, MD, MSTR's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
DISCLAIMER: Expert Institute operates independently and objectively as an expert witness data provider. This listing does not reflect or imply any existing relationship between the expert and Expert Institute. We do not employ, endorse, or maintain any affiliation with the experts listed. Information shown is automatically generated from public sources and may not be current or complete. For verified, in-depth expert data, please contact us to initiate a formal request.
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
109
Media & News
728
Social Media Mentions
Case Name | Role | Filed Date |
|---|---|---|
James Archuleta, et al. v. Cibola General Hospital Co., et al. | Expert Witness | 2017-07-25 |
Vicki Chelli, et al. v. Louis M. Komer, et al. | Expert Witness | 2013-11-01 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.

Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0

0
25
50
75
100
Institution | Degree Type |
|---|---|
University of Pennsylvania | Master of Science in Translational Research |
University of Chicago Pritzker School of Medicine | Doctor of Medicine |
University of California, Berkeley | Bachelor of Arts |
Title | Employer |
|---|---|
Leader | Vanderbilt Health (Nashville, TN) |
Physician | Vanderbilt Health (Nashville, TN) |
Co-Leader | Vanderbilt-Ingram Cancer Center (Nashville, TN) |
Donna S. Hall Chair | Vanderbilt University School of Medicine (Nashville, TN) |
Professor | Vanderbilt University School of Medicine (Nashville, TN) |
Radar found 109 records
Title | Type |
|---|---|
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026) | Journal Article |
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response | Journal Article |
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage i HER2+ Breast Cancer (ADEPT trial) | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.

Radar found 728 records
Title | Description |
|---|
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.

Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.

